Literature DB >> 26471969

The Role of Mitochondria in Cancer Induction, Progression and Changes in Metabolism.

Malgorzata Rogalinska1.   

Abstract

Mitochondria play important roles as energetic centers. Mutations in mitochondrial DNA (mtDNA) were found in several diseases, including cancers. Studies on cytoplasmic hybrids (cybrids) confirm that directed mutation introduced into mtDNA could be a reason for cancer induction. Mitochondria could also be a factor linking cancer transformation and progression. The importance of mitochondria in cancer also confirms their involvement in the resistance to treatment. Resistance to treatment of cancer cells can frequently be a reason for glycolysis acceleration. It could be explained by cancer cells' high proliferation index and high energy request. The involvement of mitochondria in metabolic disturbances of several metabolic diseases, including cancers, was reported. These data confirm that cancer induction, as well as cancer progression, could have metabolic roots. The aberrant products observed in prostate cells involved in the Krebs cycle could promote cancer progression. These multiple relationships between alterations on a genetic level translated into disturbances in cellular metabolism and their potential relation with epigenetic control of gene expression make cancerogenesis more complicated and prognoses' success in studies on cancer etiology more distant in time.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26471969     DOI: 10.2174/1389557515666151016124331

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  8 in total

1.  Single-Cell RNA Sequencing Analysis: A Step-by-Step Overview.

Authors:  Shaked Slovin; Annamaria Carissimo; Francesco Panariello; Antonio Grimaldi; Valentina Bouché; Gennaro Gambardella; Davide Cacchiarelli
Journal:  Methods Mol Biol       Date:  2021

2.  TRPM2 channel-mediated regulation of autophagy maintains mitochondrial function and promotes gastric cancer cell survival via the JNK-signaling pathway.

Authors:  Shekoufeh Almasi; Barry E Kennedy; Mariam El-Aghil; Andra M Sterea; Shashi Gujar; Santiago Partida-Sánchez; Yassine El Hiani
Journal:  J Biol Chem       Date:  2018-01-17       Impact factor: 5.157

3.  Personalized therapy tests for the monitoring of chronic lymphocytic leukemia development.

Authors:  Małgorzata Rogalińska; Paweł Góralski; Jerzy Z Błoński; Paweł Robak; Jan Barciszewski; Aneta Koceva-Chyła; Henryk Piekarski; Tadeusz Robak; Zofia M Kilianska
Journal:  Oncol Lett       Date:  2017-02-13       Impact factor: 2.967

Review 4.  The Landscape of mtDNA Modifications in Cancer: A Tale of Two Cities.

Authors:  Kate L Hertweck; Santanu Dasgupta
Journal:  Front Oncol       Date:  2017-11-02       Impact factor: 6.244

5.  Dose and drug changes in chronic lymphocytic leukemia cell response in vitro: A comparison of standard therapy regimens with two novel cyclin‑dependent kinase inhibitors.

Authors:  Małgorzata Kubczak; Aleksandra Szustka; Jerzy Z Błoński; Tomaš Gucký; Małgorzata Misiewicz; Vladmir Krystof; Paweł Robak; Małgorzata Rogalińska
Journal:  Mol Med Rep       Date:  2019-03-05       Impact factor: 2.952

6.  Cytoglobin protects cancer cells from apoptosis by regulation of mitochondrial cardiolipin.

Authors:  Lorna S Thorne; Garret Rochford; Timothy D Williams; Andrew D Southam; Giovanny Rodriguez-Blanco; Warwick B Dunn; Nikolas J Hodges
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

7.  In Vitro Evaluation of Mitochondrial Function and Estrogen Signaling in Cell Lines Exposed to the Antiseptic Cetylpyridinium Chloride.

Authors:  Sandipan Datta; Guochun He; Alexey Tomilov; Sunil Sahdeo; Michael S Denison; Gino Cortopassi
Journal:  Environ Health Perspect       Date:  2017-08-22       Impact factor: 9.031

Review 8.  Valosin-Containing Protein, a Calcium-Associated ATPase Protein, in Endoplasmic Reticulum and Mitochondrial Function and Its Implications for Diseases.

Authors:  Xiaonan Sun; Hongyu Qiu
Journal:  Int J Mol Sci       Date:  2020-05-28       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.